Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

Animal studies and preliminary results in humans suggest that lower extremity and myocardial ischemia can be attenuated by treatment with angiogenic cytokines. The resident population of endothelial cells that is competent to respond to an available level of angiogenic growth factors, however, may potentially limit the extent to which cytokine supplementation enhances tissue neovascularization. Accordingly, we transplanted human endothelial progenitor cells (hEPCs) to athymic nude mice with hindlimb ischemia. Blood flow recovery and capillary density in the ischemic hindlimb were markedly improved, and the rate of limb loss was significantly reduced. Ex vivo expanded hEPCs may thus have utility as a "supply-side" strategy for therapeutic neovascularization.

[1]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[2]  J. Isner,et al.  Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. , 1999, Circulation.

[3]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[4]  J. Isner,et al.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.

[5]  J. Isner,et al.  Age-dependent impairment of angiogenesis. , 1999, Circulation.

[6]  D. Carbone,et al.  Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. , 1998, Blood.

[7]  L. Kanz,et al.  Expansion of stem and progenitor cells. , 1998, Current opinion in hematology.

[8]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[9]  J. Isner,et al.  Mouse model of angiogenesis. , 1998, The American journal of pathology.

[10]  S. Nishikawa,et al.  Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. , 1998, Development.

[11]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[12]  M. Kennedy,et al.  A common precursor for hematopoietic and endothelial cells. , 1998, Development.

[13]  J. Isner,et al.  Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. , 1997, Circulation.

[14]  N. Schmitz,et al.  Transplantation of peripheral blood progenitor cells from HLA‐identical sibling donors , 1996, British journal of haematology.

[15]  M. Petch,et al.  Aging-associated endothelial dysfunction in humans is reversed by L-arginine. , 1996, Journal of the American College of Cardiology.

[16]  E. Dejana,et al.  Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. , 1996, Blood.

[17]  J. Isner,et al.  Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[18]  T. Lüscher,et al.  Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. , 1996, The Journal of clinical investigation.

[19]  N. Schmitz,et al.  THE PLACE OF BLOOD STEM CELLS IN ALLOGENEIC TRANSPLANTATION , 1996, British journal of haematology.

[20]  M. Creager,et al.  Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. , 1996, Hypertension.

[21]  B. Keyt,et al.  Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. , 1996, The Journal of clinical investigation.

[22]  S. Heimfeld,et al.  Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. , 1995, The New England journal of medicine.

[23]  L. Ghiadoni,et al.  Aging and endothelial function in normotensive subjects and patients with essential hypertension. , 1995, Circulation.

[24]  S. Rafii,et al.  Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion , 1994 .

[25]  M. Creager,et al.  Impaired Endothelium‐Dependent Vasodilation in Patients With Insulin‐Dependent Diabetes Mellitus , 1993, Circulation.

[26]  J. Rossant,et al.  flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. , 1993, Development.

[27]  G. Nilsson,et al.  Laser Doppler perfusion imaging by dynamic light scattering , 1993, IEEE Transactions on Biomedical Engineering.

[28]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[29]  J. Tikerpae,et al.  Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. , 1992, Journal of immunology.

[30]  H. Drexler,et al.  Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.

[31]  G. Bonadonna,et al.  Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Blood.

[32]  J. Villeval,et al.  Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. , 1988, Blood.

[33]  T. Lüscher,et al.  Endothelial dysfunction in coronary artery disease. , 1993, Annual review of medicine.